Ghrelin expression of endometrium hyperplasia and endometrioid carcinoma

Dagli A. F., Aydin S., Kocdor H., Gurates B., Sahin I., Catak Z., ...Daha Fazla

GYNECOLOGICAL ENDOCRINOLOGY, cilt.27, sa.3, ss.199-204, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 3
  • Basım Tarihi: 2011
  • Doi Numarası: 10.3109/09513590.2010.488772
  • Dergi Adı: GYNECOLOGICAL ENDOCRINOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.199-204
  • Erzincan Binali Yıldırım Üniversitesi Adresli: Evet

Özet

Background. Endometrium carcinoma ranks fourth among female carcinomas. Therefore, early diagnosis of endometrium pre-malignant lesions is emphasised, and attempts are made to identify the risk factors. Since hyperplasias, particularly those with atypia, are held responsible for the development of the most common endometrium carcinomas, it is important to definitely distinguish between well-differentiated carcinomas and hyperplasia with atypia. In the present study, we aimed to explore whether ghrelin expression had a role in distinguishing between benign, pre-malignant and malignant lesions of endometrium.